Skip to main content
Contact us

Lozenges CDMO Companies
Lozenges Contract Manufacturing Services

Your Trusted Partners for Lozenges Contract Manufacturing and Development

Applied Filters:Oral solids / OSD×Lozenges×FDF / DRUG PRODUCTS×Clear All
Showing 11 facilities
Aenova Group - Location Marburg, Germany
Germany

Aenova Group - Location Marburg, Germany

Aenova

Competence Center complex conventional solids and narcotics.

Discover our facility

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), FDA (USA), ANVISA (Brazil), Russian Health Authorities

REGION: Europe

COMPLIANCE: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: NUTRACEUTICALS, FDF / DRUG PRODUCTS

USE: Human

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Aenova Group - Location Latina, Italy
Italy

Aenova Group - Location Latina, Italy

Aenova

Competence Center animal health products and sterile technologies.

Discover our facility

MARKETS: EMA (EU), FDA (USA), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), Turkish Health Authorities

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Glatt Pharmaceutical Services GmbH Co. & KG
Germany

Glatt Pharmaceutical Services GmbH Co. & KG

Glatt Pharmaceutical Services GmbH Co. & KG

Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany.

Discover our facility

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), FDA (USA)

REGION: Europe

COMPLIANCE: FDA (cGMP), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Seda Pharma Development Services
United Kingdom

Seda Pharma Development Services

Seda Pharma Development Services Ltd

Seda Pharmaceutical Development Services specialises in integrated Pharmaceutical Development and Clinical Pharmacology.

Discover our facility

THERAPEUTIC AREAS OF EXPERTISE (ATC): (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (D) Dermatologicals, (M) Musculoskeletal system, (N) Nervous system, (B) Blood and blood forming organs

MARKETS: TGA (Australia), Rest of World, EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India)

BATCH SIZE: Small, Medium

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

COMPLIANCE: MHRA (UK GMP), ECOVADIS

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

REGION: Europe

USE: Human

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site
China

Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site

Seacross Pharmaceutical Co Ltd

The Formulation Manufacturing Site is dedicated to the development and production of complex, high-value dosage forms.

Discover our facility

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

BSL (Biological Safety Level): 3, 4, 1, 2

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: APAC

COMPLIANCE: DIGEMID, BRCGS, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, ECOVADIS, TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), French Service-Public (CIR), NMPA (China GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), SQF (Safe Quality Food), NSF

BATCH SIZE: Large, Small, Medium

USE: Human

CATEGORY / PRODUCT: SERVICES, FDF / DRUG PRODUCTS

STE PRASFARMA
Spain

STE PRASFARMA

STE PRASFARMA

CMO/CDMO cytostatics and high potency products.

Discover our facility

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

BSL (Biological Safety Level): 3, 4

CONTROLLED SUBSTANCES: High potential for abuse & medical use

COMPLIANCE: ICH, ISO, ANVISA (Brazil B-GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP)

MARKETS: EMA (EU), NMPA (China), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

BATCH SIZE: Large, Small, Medium

USE: Human

THERAPEUTIC AREAS OF EXPERTISE (ATC): (L) Antineoplastic and immunomodulating agents

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Register
Limited view

COSMETICS manufacturing site

MAI network supplier

Developer and manufacturer of new drug products with control realease technologies.

Location available after registration

Register for freeContact MAI to connect
Register
Limited view

COSMETICS manufacturing site

MAI network supplier

One-stop CDMO Solutions for APl and Key intermediates.

Location available after registration

Register for freeContact MAI to connect
Register
Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

French CDMO key player in drug development and delivery of oral technologies serving the pharma and bio industries.

Location available after registration

Register for freeContact MAI to connect

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+2 more facilities

Create free account

Lozenges are a popular dosage form for delivering active ingredients locally in the mouth or throat, as well as for systemic absorption via buccal or sublingual routes. Whether you’re developing medicated lozenges, herbal formulations, or innovative delivery systems, working with experienced lozenges CDMO companies ensures precision, compliance, and patient-friendly design.

From formulation and flavoring to compression and GMP packaging, full-service lozenges contract manufacturing partners help you bring stable, palatable, and effective products to market quickly and efficiently.

How to Choose Lozenges CDMO Companies

When selecting among lozenges CDMO companies, it’s essential to assess both technical expertise and production capabilities. Key factors to consider include:

  • Formulation capabilities: Medicated, herbal, vitamin-based, or functional ingredients
  • Lozenge types: Compressed, molded, soft-chew, or hard candy formats
  • Flavor masking expertise for bitter APIs or strong actives
  • Heat sensitivity handling during processing
  • Uniformity of dosage in multiparticulate systems
  • Regulatory compliance with FDA, EMA, and other health agencies for OTC or Rx products
  • Packaging options: Blister packs, jars, strips, and foil pouches

Choosing a CDMO with proven lozenge experience minimizes risk and accelerates development timelines.

Key Services Offered by Lozenges Contract Manufacturers

Top-tier lozenges contract manufacturing companies typically offer:

  • Pre-formulation and R&D for flavor, texture, and mouthfeel optimization
  • Compression and molding technologies for various lozenge formats
  • Flavor masking and sweetening system development
  • Stability testing and shelf-life studies under ICH guidelines
  • Color and shape customization for brand differentiation
  • Moisture protection strategies through formulation and packaging
  • Primary and secondary packaging with tamper-evident features
  • Regulatory support for OTC monograph compliance or NDA/ANDA submissions

These services ensure your lozenges are effective, stable, and enjoyable to use.

Advantages of Partnering with Lozenges CDMO Companies

Collaborating with expert lozenges CDMO companies offers key benefits:

  • Improved patient compliance with pleasant-tasting, easy-to-use formats
  • Flexible dosage form customization to fit your therapeutic goals
  • Efficient scale-up from pilot batches to full commercial production
  • Support for both nutraceutical and pharmaceutical markets
  • Cost-effective manufacturing through proven lozenge processes

Whether delivering APIs, botanicals, or vitamins, the right CDMO can enhance both product performance and user experience.

Lozenges CDMO Companies

Some of the top lozenges CDMO companies include:

  • Aenova: Competence Center and one-stop shop for Soft gelatin capsules and VegaGels®. [See CDMO profile]
  • Sichuan Huiyu Pharmaceuticals: Specialize in services for APIs and complex injectables, including implants, liposomes, high-potency, oncology, cytotoxic, and corticosteroid drugs. [See CDMO profile]
  • I+Med: Developer and manufacturer of new drug products with controlled-release technologies, including nasal. [See CDMO profile]
  • Skyepharma: Global player in oral delivery technologies for pharma, biotech, and consumer health. [See CDMO profile]
  • Darnytsia Kyiv: Manufacturer with stringent quality control and innovative solutions in oral liquids, semisolids, and oral solid dosage forms (OSD). [See CDMO profile]

Related Information

Let MAI CDMO Help You Find the Right Lozenges CDMO Partner

At MAI CDMO, we specialize in connecting you with leading lozenges CDMO companies that match your product goals — whether you’re developing a medicated throat lozenge, a botanical extract product, or an innovative buccal formulation. Our network of lozenges contract manufacturing partners ensures regulatory compliance, great taste, and scalable production.

Ready to sweeten your manufacturing strategy? Contact us today and find your perfect lozenge CDMO match.